The European Paediatric Network for Haemophilia Management ( PedNet Registry)
The PedNet Registry is an international study focusing on children born with haemophilia A or B. Because haemophilia is a rare condition, doctors collaborate across many hospitals to gather enough information. The main goal is to learn more about bleeding episodes in babies, understand why some children develop 'inhibitors' (which can make treatment harder), and see how children with haemophilia fare over time. The study simply collects details about the child's usual medical care from their records, without adding extra appointments or tests. This helps researchers improve future care and guidance for all children with haemophilia, even though individual participants won't notice a direct change in their health.
En un coup d'œil
De quoi parle cette étude ?
Haemophilia is a rare condition where blood doesn’t clot properly, leading to bleeding problems. Because it's so uncommon, it's hard for one hospital alone to gather enough information to understand it fully. This is why the PedNet Registry was created – it’s a big study involving many hospitals across Europe. The main idea is to collect health information from lots of children with haemophilia A or B, all born between 2000 and 2040.
The study wants to learn several key things. For example, it looks at bleeding in newborn babies, and tries to understand why some children develop 'inhibitors.' Inhibitors are like antibodies that can make the usual haemophilia treatment less effective. The study also tracks the long-term health of these children, particularly how their joints are affected over time. By looking at a large group of children, researchers hope to find patterns and factors that influence these important aspects of haemophilia.
It's important to know that this is an 'observational' study. This means your child will not receive any new treatments or interventions specifically for this study. Instead, doctors will simply record information from your child's regular medical care, including details about their diagnosis, treatments, and any bleeding episodes. This information is usually collected anyway as part of their routine check-ups. The aim is to use this de-identified data to create better guidelines and improve care for all children with haemophilia in the future.
Points clés
- It's a study for children with haemophilia A or B.
- No new treatments or extra appointments are involved.
- Doctors will use information from your child’s routine medical records.
- The study aims to understand bleeding, 'inhibitors', and long-term health in children with haemophilia.
- It helps develop better care and guidelines for all children with haemophilia.
- Your child will not have any direct individual health benefits from participating.
Qui peut être éligible ?
To be part of this study, a child would generally need to have been diagnosed with haemophilia A or B. Their Factor VIII or IX levels (which measure how well their blood clots) should be between less than 1% and 25%.
They also need to have detailed medical records about their haemophilia treatment and any bleeding episodes. Finally, the child must be receiving care at one of the hospitals participating in this study.
A child cannot join if they were referred to a hospital specifically because they already have an 'inhibitor' (a complication that can make treatment harder), or if the parents/guardians do not give their permission.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Does your child have haemophilia A or B?
- Are their Factor VIII/IX levels between less than 1% and 25%?
- Are their medical records for treatment and bleeds complete?
- Is your child currently treated at a hospital taking part in this study?
- Was your child *not* referred to this hospital specifically because they already have an inhibitor?
En quoi consiste la participation ?
If your child takes part in this study, you won't notice any changes to their medical care. There are no extra hospital visits, tests, or medication involved. The doctors and nurses will simply gather information from your child's existing medical records and from their routine check-ups. This includes details like their Factor VIII or IX levels, family history, genetic information, treatment records, and how their joints are doing. They will also record any bleeding episodes. All the information collected is part of the standard care your child would receive anyway, so it doesn't add any extra burden. The study will continue for many years, following children born between 2000 and 2040, but your child's individual participation simply involves allowing their routine medical data to be used.
Risques et avantages potentiels
Locations (39)
- Universitäts-Klinik für Kinder- und JugendheilkundeCode postal vérifiéGraz, Autriche· Terminé
- Medical University of Vienna - Department of PaediatricsCode postal vérifiéVienne, Autriche· Recrutement
- Service of Pediatric Haematology University Hospital LeuvenCode postal vérifiéLeuven, Belgium· Recrutement
- Division of Hematology/Oncology Hôpital St JustineCode postal vérifiéMontréal, Canada· Recrutement
- Division of Haematology/Oncology Hospital for Sick ChildrenCode postal vérifiéToronto, Canada· Recrutement
- Haemophilia Comprehensive Care Centre, Centre for Thrombosis and Haemostasis Children's University Hospital BrnoCode postal vérifiéBrno, Tchéquie· Recrutement
- Department of Paediatric Haematology/oncology - University Hospital MotolCode postal vérifiéPrague, Tchéquie· Recrutement
- Department of Pediatrics Århus Kommunehospital Skejby SygehusCode postal vérifiéAarhus, Denmark· Recrutement
- Children's Hospital Helsinki University HospitalCode postal vérifiéHelsinki, Finland· Recrutement
- Service Hématologique Centre Regional Traitement d'Hemophilie BicetreCode postal vérifiéLe Kremlin-Bicêtre, France· Recrutement
- Service d'Hématologie Pédiatrique Hôpital Universitaire La TimoneNon vérifiéMarseille Cedex-05, France· Recrutement
- Centre de traitement des hémophiles Hôpital Universitaire PurpanCode postal vérifiéToulouse, France· Recrutement
Questions fréquentes
Qu'est-ce que l'hémophilie ?
Haemophilia is a rare inherited condition where blood doesn't clot properly, which can lead to longer bleeding after an injury or surgery.
What is an 'inhibitor'?
An 'inhibitor' is when the body creates antibodies against the treatment for haemophilia, making the treatment less effective.
Will my child get new medicines for this study?
No, your child will not receive any new medicines or treatments specifically for this study. Doctors will only record details of their usual care.
Will we have extra hospital visits?
No, taking part in this study will not mean any extra visits to the hospital. All information is collected during your child's routine appointments.
How will this study help?
By collecting information from many children, doctors hope to understand haemophilia better, which can lead to improved treatments and guidelines for all children with the condition in the future.
Comment en savoir plus
Angelique Hermeling
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Intéressé à participer ?
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.